These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Lysozyme in hematologic diseases]. Zittoun J; Zittoun R Sem Hop; 1975 Jan; 51(4):247-52. PubMed ID: 167445 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies. Wiernik PH; Serpick AA Am J Med; 1969 Mar; 46(3):330-43. PubMed ID: 4888852 [No Abstract] [Full Text] [Related]
4. [Serum lysozyme in some haematological diseases (author's transl)]. Bláha M; Procházková J; Wagenknecht D; Vanásek J; Siroký O Cas Lek Cesk; 1978 Jul; 117(27):827-9. PubMed ID: 278647 [No Abstract] [Full Text] [Related]
5. [Activity of muramidase in blood system diseases in children]. Ostrovskiĭ AD; Zeĭts RI Vopr Okhr Materin Det; 1977 Jul; 22(7):55-8. PubMed ID: 906381 [No Abstract] [Full Text] [Related]
6. Studies on muramidase in hematologic disorders. I. Serum muramidase and serum lactic dehydrogenase in leukemia. Levi JA; Speden JB; Vincent PC; Gunz FW Cancer; 1973 Apr; 31(4):939-47. PubMed ID: 4513296 [No Abstract] [Full Text] [Related]
9. [Serum and urine lysozyme activity in various blood disorders and hypopotassemia in leukemia]. Shimizu M; Takabayashi Y; Asai I; Nishina T; Niwa S Rinsho Ketsueki; 1972 Aug; 13(4):549-59. PubMed ID: 4509361 [No Abstract] [Full Text] [Related]
10. [The significance of muramidase (lysozyme) determinations in hematologic diseases]. Mets T; Carlier A; Van Hove W Ned Tijdschr Geneeskd; 1976 Nov; 120(47):2039-44. PubMed ID: 1070575 [No Abstract] [Full Text] [Related]
11. [Early diagnosis of malignant blood diseases]. Heckner F Z Allgemeinmed; 1969 Oct; 45(30):1423-6. PubMed ID: 5271561 [No Abstract] [Full Text] [Related]
12. [Analysis for telomerase activity in various hematologic disorders]. Kosugi H; Saito H Nihon Rinsho; 1998 May; 56(5):1316-21. PubMed ID: 9613144 [TBL] [Abstract][Full Text] [Related]
13. [Immunoglobulin determination in hematologic system diseases]. Rehn K; Hunstein W; Schreiter B; Uhl N Verh Dtsch Ges Inn Med; 1971; 77():1397-400. PubMed ID: 5156041 [No Abstract] [Full Text] [Related]
14. Poly(2'-O-methylcytidylate)-directed DNA polymerase and terminal deoxynucleotidyltransferase activities in particulate fractions obtained from human spleens. Marcus SL; Kopelman R Cancer Res; 1980 Apr; 40(4):1014-21. PubMed ID: 6153571 [No Abstract] [Full Text] [Related]
15. Ratio of glutamine aminotransferase & glutamine aminohydrolase in plasma of patients with malignant & other blood disorders. Chakraborty P; Chowdhuri MD; Shrivastava GC Indian J Exp Biol; 1974 Jul; 12(4):315-7. PubMed ID: 4457460 [No Abstract] [Full Text] [Related]
16. [The liver in blood diseases]. Crismer R Arch Fr Mal App Dig; 1972; 61(4):425-32. PubMed ID: 4263030 [No Abstract] [Full Text] [Related]
17. Muramidase in leukaemia. Br Med J; 1969 Oct; 4(5677):183. PubMed ID: 5349295 [No Abstract] [Full Text] [Related]
18. [R.A. (rheumatoid agglutination) test of patients with blood and liver diseases]. Sonoda N; Kanemitsu T Iryo; 1968 Nov; 22(11):1291-5. PubMed ID: 5717001 [No Abstract] [Full Text] [Related]
19. [Adenosine deaminase activity in hemoblastoses]. Krüger W; Müller G; Storch H; Kubel M; Richter V Arch Geschwulstforsch; 1983; 53(1):53-9. PubMed ID: 6574729 [TBL] [Abstract][Full Text] [Related]
20. [Detection of muramidase by indirect cytochemical (cytobacterial) method, its significance in the differential diagnosis of hemoblastoses]. Katalin N; János S; Miklósné B; Oszkárné R; Zsuzsa H Orv Hetil; 1976; 117(18):1080-4. PubMed ID: 1272563 [No Abstract] [Full Text] [Related] [Next] [New Search]